ZD1839, AN EPIDERMAL GROWTH FACTOR TYROSINE KINASE INHIBITOR SELECTED FOR CLINICAL DEVELOPMENT

Publisher Website

1 September 1997

journal article
Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Immunotherapy

Vol. 20 (5), 408
https://doi.org/10.1097/00002371-199709000-00044

Abstract

No abstract available

Cited by 15 articles